Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Other Non-Current Assets (2012 - 2024)

Kamada's (KMDA) quarterly Other Non-Current Assets came in at $112000.0 in Q4 2024, down 96.69% quarter-over-quarter from $3.4 million in Q3 2021.

Analysis

Kamada (KMDA) Other Non-Current Assets (2012 - 2024) Analysis & Trends

Kamada (KMDA) has reported Other Non-Current Assets for 11 consecutive years, with $112000.0 the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Assets changed N/A year-over-year to $112000.0; the trailing twelve-month figure through Dec 2024 stood at $112000.0 (changed N/A YoY), and the FY2024 full-year result was $112000.0, changed N/A from the prior year.
  • Other Non-Current Assets declined to $112000.0 in Q4 2024 per KMDA's latest filing, from $3.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $3.4 million in Q2 2021 and bottomed at $112000.0 in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $1.9 million across 3 years, with a median of $1.3 million in 2020.
  • The sharpest annual moves came in 2020 and 2021: Other Non-Current Assets soared 508.05% in 2020, then soared 201.52% in 2021.
  • Over 3 years, Other Non-Current Assets stood at $1.6 million in 2020, then surged by 114.88% to $3.4 million in 2021, then sank by 96.69% to $112000.0 in 2024.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $112000.0, $3.4 million, and $3.4 million for Q4 2024, Q3 2021, and Q2 2021 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 211.39 Bn 197.40 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 181.14 Bn 177.96 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 132.24 Bn 124.39 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.91 Bn 74.91 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 61.55 Bn 56.36 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.39 Bn 49.25 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 34.43 Bn 31.12 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.18 Bn 29.89 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn 29.59 Mn
10 Kamada 472.70 Mn 402.57 Mn 22.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 112,000.00
Sep 30, 2021 3.38 Mn
Jun 30, 2021 3.41 Mn
Mar 31, 2021 3.18 Mn
Dec 31, 2020 1.57 Mn
Sep 30, 2020 1.08 Mn
Jun 30, 2020 1.06 Mn
Mar 31, 2020 1.05 Mn
Dec 31, 2019 352,000.00
Sep 30, 2019 178,000.00
Jun 30, 2019 174,000.00
Mar 31, 2019 174,000.00
Dec 31, 2018 174,000.00
Sep 30, 2018 176,000.00
Jun 30, 2018 173,000.00
Mar 31, 2018 173,000.00
Dec 31, 2017 49,000.00
Sep 30, 2017 443,000.00
Jun 30, 2017 404,000.00
Mar 31, 2017 372,000.00